Leng, S., Bhutani, D., Raza, S., Assal, A., Pan, S., Hu, J., . . . Lentzsch, S. (2020). Phase I/II study of carfilzomib, bendamustine, and dexamethasone (CBD) in patients with newly diagnosed multiple myeloma. Blood Cancer J.

Leng, Siyang, Divaya Bhutani, Shahzad Raza, Amer Assal, Samuel Pan, Jianhua Hu, Alexander Wei, Markus Mapara, και Suzanne Lentzsch. "Phase I/II Study of Carfilzomib, Bendamustine, and Dexamethasone (CBD) in Patients With Newly Diagnosed Multiple Myeloma." Blood Cancer J 2020.

Leng, Siyang, et al. "Phase I/II Study of Carfilzomib, Bendamustine, and Dexamethasone (CBD) in Patients With Newly Diagnosed Multiple Myeloma." Blood Cancer J 2020.